The “60 vote” bar on the public option was always a sham. But now that it’s gone, nobody wants to be Joe Lieberman and play the role of spoiler so PhRMA can have their deal. Ezra Klein reports: I’ve spoken to a lot of offices about this now, and all of them are ambivalent privately, [...]